Interestingly, among the probands with de novo mutations in the DYNC1H1 gene, one proband had clinical symptoms of EE (LGS), and 4 additional probands also possessed epileptic features. This evidence concerns the gene DYNC1H1 and ethylmalonic encephalopathy.